Hazardous Medical Solution Supply and Packaging

The contract entails the procurement, packaging, and labeling of a hazardous intravenous solution composed of Dextrose, Potassium Chloride, and Sodium Chloride in 1000 mL containers, with 14 units per packing group, all adhering strictly to military and federal hazardous material regulations. This supply effort is critical for ensuring safe handling, transport, and deployment of life-sustaining IV fluids within defense medical operations, requiring full compliance with established safety and packaging standards for hazardous pharmaceuticals. The solution must be manufactured and packaged in a manner that maintains integrity during transit and meets all applicable Department of Defense requirements for hazardous substance management. The solicitation, issued under the NAICS code 325412 for Pharmaceutical Preparation Manufacturing, is a subcontract opportunity managed by the Medical Supply Chain Pharm FSA under the Department of Defense, with performance required at Fort Stewart, Georgia, ZIP 31314-5185. Responses are due by August 3, 2026, following a posting date of July 26, 2026. All parties must ensure the product meets exacting specifications for chemical composition, labeling accuracy, and hazard communication as mandated by regulatory frameworks governing hazardous materials in federal and military contexts, with no set-aside provisions specified. Access to further details is available through the official DIBBS platform.